Black Diamond Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Black Diamond Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q1 2024.
  • Black Diamond Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $86K, a 29.5% decline year-over-year.
  • Black Diamond Therapeutics, Inc. annual Depreciation for 2023 was $437K, a 14% decline from 2022.
  • Black Diamond Therapeutics, Inc. annual Depreciation for 2022 was $508K, a 148% increase from 2021.
  • Black Diamond Therapeutics, Inc. annual Depreciation for 2021 was $205K, a 294% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $86K -$36K -29.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $122K -$3K -2.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $125K +$106K +558% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $19K +$9K +90% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q1 2020 $10K -$2K -16.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $12K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.